Lipid Nanoparticles: Powering mRNA Delivery

Jason is the site head of technical operations at Merck's Drug Product and LNP Center of Excellence in Indianapolis. He previously worked in the CDMO industry for 4 years, leading drug substance and drug product manufacturing teams and the site MS&T/technical support and validation team. Jason also directed a commercial plasma fractionation operation for more than 12 years. He holds a bachelor’s degree in science, Six Sigma and Lean certifications, and General Manager Leadership certifications.

Pamela is a technical consultant in Merck's contract testing services team, supporting clients with scientific, technical, and regulatory advice related to the quality control testing required for the development and commercialization of biological therapies and novel modalities. She previously worked as a principal scientist in our contract testing services UK facilities, overseeing clients' custom cell-based and immunoassay development and providing associated technical and regulatory support. Pamela has a Ph.D. in virology from the University of Glasgow.

Roland Böttger received his Ph.D. in chemistry from University of Leipzig (Germany) in 2018 and completed postdoctoral training focused on nanomedicine at University of British Columbia (Canada) in 2020. He is now a senior scientist at CureVac (Germany), developing mRNA delivery systems for prophylactic and therapeutic vaccine applications. In addition, he works on liquid and dried mRNA presentations with improved stability.

Eleni is a principal scientist in the early formulation screening service team. She is a chemical engineer by training and holds a MSc in biochemistry and a Ph.D. in nanomedicine, followed by postdoctoral research experience on advanced drug delivery. Eleni brings more than 8 years of hands-on experience on the development of lipid-based formulations for RNA delivery applications, having served previously as a scientist at BioNTech SE, Mainz, Germany, and, at Genevant Sciences, Vancouver, Canada.